Similar Items: Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancer
- Revised tumor burden score for prognostic stratification in metastatic colorectal cancer patients receiving immunotherapy: a retrospective study
- The prognostic value of baseline hematological parameters of peripheral blood in metastatic gastric cancer treated with apatinib
- Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
- Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial
- Maintenance Metronomic Chemotherapy in Treatment of Metastatic Colorectal Cancer
- Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer